cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Avid Bioservices Inc
3 own
4 watching
Current Price
$0
$-0.13
(-0.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,076.02M
52-Week High
52-Week High
21.05
52-Week Low
52-Week Low
11.34
Average Volume
Average Volume
0.14M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
354.2635
iconMarket Capitalization1,076.02M
icon52-Week High21.05
icon52-Week Low11.34
iconAverage Volume0.14M
iconDividend Yield--
iconP/E Ratio354.2635
What does the Avid Bioservices Inc do?
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Read More
How much money does Avid Bioservices Inc make?
News & Events about Avid Bioservices Inc.
Zolmax
1month ago
Avid Bioservices, Inc. (NASDAQ:CDMO Get Rating) General Mark R. Ziebell sold 25,000 shares of the stock in a transaction dated Monday, May 1st. The stock was sold at an average price of $17.91, for a total transaction of $447,750.00. Following the completion of the transaction, the general now ...
Ticker Report
1month ago
Avid Bioservices, Inc. (NASDAQ:CDMO Get Rating) General Mark R. Ziebell sold 25,000 shares of the companys stock in a transaction on Monday, May 1st. The shares were sold at an average price of $17.91, for a total transaction of $447,750.00. Following the sale, the general now ...
Ticker Report
1month ago
Avid Bioservices, Inc. (NASDAQ:CDMO Get Rating) CEO Nicholas Stewart Green sold 7,598 shares of the firms stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $19.80, for a total transaction of $150,440.40. Following the completion of the ...
Ticker Report
1month ago
Avid Bioservices, Inc. (NASDAQ:CDMO Get Rating) CFO Daniel R. Hart sold 1,250 shares of the companys stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $19.00, for a total value of $23,750.00. Following the sale, the chief financial...
Ticker Report
2 months ago
Shares of Avid Bioservices, Inc. (NASDAQ:CDMO Get Rating) gapped up prior to trading on Tuesday . The stock had previously closed at $13.82, but opened at $16.90. Avid Bioservices shares last traded at $17.23, with a volume of 506,381 shares trading hands. Analysts Set New Price Targets A ...
Frequently Asked Questions
Frequently Asked Questions
What is Avid Bioservices Inc share price today?
plus_minus_icon
Can Indians buy Avid Bioservices Inc shares?
plus_minus_icon
How can I buy Avid Bioservices Inc shares from India?
plus_minus_icon
Can Fractional shares of Avid Bioservices Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Avid Bioservices Inc stocks?
plus_minus_icon
What is today’s traded volume of Avid Bioservices Inc?
plus_minus_icon
What is today’s market capitalisation of Avid Bioservices Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Avid Bioservices Inc?
plus_minus_icon
What percentage is Avid Bioservices Inc down from its 52-Week High?
plus_minus_icon
What percentage is Avid Bioservices Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.13
(-0.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
INHIBRX INC
INHIBRX INC
$24.48
$-0.18 (-0.73 %)
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
$21.91
$-0.19 (-0.86 %)
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$15.08
$-0.10 (-0.66 %)
Cassava Sciences Inc
Cassava Sciences Inc
$24.57
$0.56 (2.33 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
INHIBRX INC
INHIBRX INC
$24.48
$-0.18 (-0.73 %)
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
$21.91
$-0.19 (-0.86 %)
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$15.08
$-0.10 (-0.66 %)
Cassava Sciences Inc
Cassava Sciences Inc
$24.57
$0.56 (2.33 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00